No. PAR-25-053 · National Institutes of Health
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
- Award range
- Not specified
- Expected awards
- Not specified
- Application deadline
- Jan 28, 2027
- Posted
- Oct 29, 2024
- Last verified
- 7 days ago
At a glance
AI summaryThis program funds non-clinical testing and then, if approved, a small non-significant-risk clinical study for neurological devices within NINDS’s mission. Projects must use a two-phase R61/R33 structure, and only R61 projects that meet milestones and receive administrative review can move to R33. The total project period may not exceed five years, with the R61 phase up to two years and the R33 phase up to four years. Eligible applicants include a wide range of U.S. and foreign organizations, and no cost sharing is required.
AI-generated summary — verify against the announcement
What it funds
Official description from grants.gov
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, as well as a subsequent small clinical study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This NOFO is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.
Who can apply
- City or township governments
- County governments
- For-profit organizations other than small businesses
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Others
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Small businesses
- Special district governments
- State governments
Program history
USASpending.govAssistance listing 93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders
Real awards this federal program has made — the whole assistance listing (93.853), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 654 | $405,461 | $120,825 – $587,738 |
| FY 2025 | 923 | $491,085 | $157,949 – $1,077,840 |
| FY 2024 | 1,031 | — | — |
| FY 2023 | 1,194 | — | — |
| FY 2022 | 1,228 | — | — |
| FY 2021 | 1,132 | — | — |
Dollar figures are based on the 1,000 most recent awards we store, not all 6,162 — award counts are complete.
- THE LELAND STANFORD JUNIOR UNIVERSITY $5,747,701 · FY 2025
- YALE UNIV $4,888,497 · FY 2025
- MAYO CLINIC $3,746,535 · FY 2026
- REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE $3,153,019 · FY 2025
- UNIVERSITY OF CALIFORNIA, LOS ANGELES $3,109,857 · FY 2025
Source: USASpending.gov · refreshed Aug 23, 2026